Buscar
08/04/2025
To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis Diagnosis
Vidal-Jordana, A, Ontaneda, D. To Kill Time: A Bold Step Toward Simplifying Multiple Sclerosis Diagnosis. NEUROLOGY. 2025; 104(7)DOI:10.1212/WNL.0000000000213416. PMID:40036710. IF:8.500(Q1/1D).
05/04/2025
Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE e4-Linked Methylation Signatures
Macías, M, Alba-Linares, JJ, Acha, B, Blanco-Luquin, I, Fernández, AF, Alvarez-Jiménez, J, Urdánoz-Casado, A, Roldan, M, Robles, M, Cabezon-Arteta, E, Alcolea, D, de Gordoa, JSR, Corroza, J, Cabello, C, Erro, ME, Jericó, I, Fraga, MF, Mendioroz, M. Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE e4-Linked Methylation Signatures. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(7)DOI:10.3390/ijms26073419. PMID:40244264. IF:4.900(Q1/3D).
04/04/2025
Design and Validation of a Simplified Method to Determine Minimum Bactericidal Concentration in Nontuberculous Mycobacteria
Batista, S, Fernandez-Pittol, M, San Nicolás, L, Martínez, D, Narváez, S, Espasa, M, Losilla, EG, Rubio, M, Garrigo, M, Tudó, G, González-Martin, J. Design and Validation of a Simplified Method to Determine Minimum Bactericidal Concentration in Nontuberculous Mycobacteria. Antibiotics-Basel. 2025; 14(4)DOI:10.3390/antibiotics14040381. PMID:40298560. IF:4.600(Q1/2D).
03/04/2025
OCTA and Microperimetry Changes Preceding the Appearance of Diabetic Retinopathy in Patients with Type 1 Diabetes
Rego-Lorca, D, Mateu-Salat, M, Chico, A, Molina-Montero, A, Díaz-Cascajosa, J, Vela-Segarra, JI. OCTA and Microperimetry Changes Preceding the Appearance of Diabetic Retinopathy in Patients with Type 1 Diabetes. CURRENT EYE RESEARCH. 2025; 50(4)DOI:10.1080/02713683.2024.2435357. PMID:39637437. IF:2.000(Q2/5D).
03/04/2025
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome
Alcover, S, Ramos-Regalado, L, Girón, G, Muñoz-García, N, Vilahur, G. HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome. Antioxidants. 2025; 14(4)DOI:10.3390/antiox14040434. PMID:40298782. IF:6.600(Q1/1D).
02/04/2025
Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes
Barranco-Altirriba, M, Rossell, J, Alonso, N, Weber, RJM, Ortega, E, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Winder, C, Junza, A, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02701-z. PMID:40176064. IF:10.600(Q1/1D).
01/04/2025
Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial
Marchina, S, Yeatts, SD, Foster, LD, Janis, S, Shoamanesh, A, Khatri, P, Bernstein, K, Perlmutter, A, Stever, C, Heistand, EC, Broderick, JP, Greenberg, SM, Leira, EC, Rosand, J, Lioutas, VA, Salman, RA, Tirschwell, D, Marti-Fabregas, J, Selim, M. Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial. CEREBROVASCULAR DISEASES. 2025; 54(2)DOI:10.1159/000538195. PMID:38493765. IF:1.500(Q3/8D).
01/04/2025
Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease
Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Rusiñol, AB, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martínez, SM, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Rodríguez-Molinero, A. Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease. Clinical Parkinsonism & Related Disorders. 2025; 12DOI:10.1016/j.prdoa.2025.100325. PMID:40329979. IF:(Q/D).